Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans
- 1 December 1995
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 33 (12), 3154-8
- https://doi.org/10.1128/jcm.33.12.3154-3158.1995
Abstract
The National Committee for Clinical Laboratory Standards has proposed a reference broth macrodilution method for in vitro antifungal susceptibility testing of yeasts (the M27-P method). This method is cumbersome and time-consuming and includes MIC endpoint determination by the visual and subjective inspection of growth inhibition after 48 h of incubation. Two alternative microdilution procedures for MIC endpoint determination, a spectrophotometric MIC endpoint test that evaluates 80% growth inhibition by the drug and a colorimetric method with an oxidation-reduction indicator (Alamar Blue), were compared with the M27-P method for fluconazole susceptibility testing of 45 susceptible and resistant isolates of Candida albicans. The spectrophotometric method was performed with RPMI 1640 medium with 2% glucose, and the other two tests were performed with plain RPMI 1640 medium. All tests were incubated at 35 degrees C. Excellent agreement was demonstrated between the M27-P method and both 24-h microdilution tests (97.7%) as well as between the two microdilution tests (95.5%). Also, there was agreement in the detection in vivo of fluconazole resistance by the three methods. These preliminary data indicate that both microdilution methods may serve as less subjective alternatives to the M27-P method for the determination of fluconazole MIC endpoints.Keywords
This publication has 17 references indexed in Scilit:
- Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patientsJournal of Antimicrobial Chemotherapy, 1995
- Importance of Candida Species Other than C. albicans as Pathogens in Oncology PatientsClinical Infectious Diseases, 1995
- Evaluation of 80% inhibition standards for the determination of fluconazole minimum inhibitory concentrations in three laboratoriesDiagnostic Microbiology and Infectious Disease, 1994
- Etest for antifungal susceptibility testing of yeastsDiagnostic Microbiology and Infectious Disease, 1994
- Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year periodAntimicrobial Agents and Chemotherapy, 1994
- Improved medium for fluconazole susceptibility testing of Candida albicansAntimicrobial Agents and Chemotherapy, 1994
- Turbidimetric and visual criteria for determining the in vitro activity of six antifungal agents againstCandida spp. andCryptococcus neoformansMycopathologia, 1993
- Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990The Journal of Infectious Diseases, 1993
- Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeastsAntimicrobial Agents and Chemotherapy, 1993
- Levels of gamma-glutamyltranspeptidase in cultured skin fibroblasts from cystinotics and normalsLife Sciences, 1980